Company intelligence / Profile preview

H&D Asset Management

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

H&D Asset Management is a South Korean investment firm that specializes exclusively in the life sciences and biotechnology sectors. Founded in 2020, the company focuses on identifying and funding high-potential biotech startups and growth-stage companies, particularly those developing innovative therapeutic platforms. The firm manages specialized bio-funds and provides strategic guidance to its portfolio companies, which include several prominent Korean drug developers. H&D Asset Management is recognized for its deep industry expertise and its role in fostering the Korean biotech ecosystem through targeted venture capital and private equity investments.

Industry: Investors

Beyond the preview

Go deeper on H&D Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H&D Asset Management.

Explore the full profile